Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Mayo Clinic
University of Michigan Rogel Cancer Center
OHSU Knight Cancer Institute
University of Washington
Jonsson Comprehensive Cancer Center
Columbia University